SEC Form 4 · accession 0001078782-18-001003
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
May 1, 2018
Accepted (ET)
Sep 17, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2018 | P | 5,000,000 | $0.10 | A | 20,038,831 | D | |
| Common Stock | Sep 17, 2018 | P | 17,000 | $0.14 | A | 20,055,831 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase WarrantF1 | $0.10 | May 16, 2018 | A | 5,000,000 | A | May 16, 2018 | May 16, 2023 | Common Stock | 5,000,000 | 5,000,000 | D |
Explanation of responses
- F1Acquired in a private transaction from a 3rd party.